ATF3 and obesity disorder: Using various obesity-related DN mouse models, we showed that ST32da-induced ATF3 benefits obesity-related DN and improves high-glucose-induced inflammatory reactions in mesangial cells by inhibiting the proapoptotic molecule RARRES1, activated via the paracrine pathway.